标普生物科技LOF(161127)
动态评分： 5.92分
投资组合
| 报告日期 | 代码 | 名称 | 金额(万元) | 比例 |
| 2023-03-31 | MRNA | Moderna Inc | 294.76 | 1.02% |
| 2023-03-31 | REGN | 再生元制药 | 291.91 | 1.01% |
| 2023-03-31 | VRTX | 福泰制药 | 291.2 | 1.01% |
| 2023-03-31 | RCUS | Arcus Biosciences Inc | 292.48 | 1.01% |
| 2022-12-31 | MDGL | Madrigal Pharmaceuticals Inc | 1118.28 | 3.45% |
| 2022-12-31 | ARWR | Arrowhead Pharmaceuticals Inc | 394.86 | 1.22% |
| 2022-12-31 | CYTK | Cytokinetics Inc | 376.75 | 1.16% |
| 2022-12-31 | AKRO | Akero Therapeutics Inc | 366.55 | 1.13% |
| 2022-12-31 | ALT | Altimmune Inc | 358.44 | 1.11% |
| 2022-12-31 | HZNP | Horizon Therapeutics plc | 344.45 | 1.06% |
| 2022-12-31 | CPRX | Catalyst Pharmaceuticals Inc | 334.4 | 1.03% |
| 2022-12-31 | RARE | Ultragenyx Pharmaceutical Inc | 335.51 | 1.03% |
| 2022-12-31 | PCVX | Vaxcyte Inc | 331.72 | 1.02% |
| 2022-12-31 | EXAS | 精密科学 | 326.92 | 1.01% |
| 2022-09-30 | BIIB | 生化基因 | 426.14 | 1.31% |
| 2022-09-30 | APLS | Apellis Pharmaceuticals Inc | 341.87 | 1.05% |
| 2022-09-30 | SWTX | SpringWorks Therapeutics Inc | 340.36 | 1.05% |
| 2022-09-30 | BHVN | Biohaven Pharmaceutical Holding Co Ltd | 339.16 | 1.04% |
| 2022-09-30 | GBT | 全球血液疗法 | 339.9 | 1.04% |
| 2022-09-30 | CCXI | ChemoCentryx Inc | 339.34 | 1.04% |
公告&资料
